HIV and methamphetamine (METH) commonly co-occur and remain a major burden on the healthcare system, due in part to their individual and combined toxic effects on neural systems that underlie higher-level neurocognitive functions, such as risky decision-making. Building on the accomplishments of the prior 3 years of funding, this renewal application of the Translational Methamphetamine AIDS Research Center (TMARC) will elucidate the neurobiological mechanisms and everyday impact of METH/HIV-induced central nervous system (CNS) injury using a translational approach guided by a conceptual model that emphasizes both continuity (e.g., decision-making) and novel (e.g., aging, social cognition) themes. Human research Projects will examine the effects of HIV, METH, and aging on: risk taking, decision-making, and inhibitory deficits (P1);functional and structural connectivity in risk taking (P2);and social cognition and HIV transmission risk (P3). Extending and complementing the human studies are 2 animal Projects using HIV/gp120 and inducible Tat transgenic mouse models, which will examine the effects of METH and aging on cognition and social behavior (P4), as well as gene expression in the context of behavioral and neuropathological changes (P5). A third animal Project, nested within P1, will enhance translation of the human studies on decision-making to animals. TMARC will provide scientific leadership, technical support, and opportunities for training to coalesce the efforts of an interdisciplinary group of Investigators, which will include 3 scientific Cores (i.e., Behavioral Assessment and Medical;Neuroimaging;and Neuroscience and Animal Models). The renewal also includes a new Pilot and Developmental Core, which will support innovative pilot studies and foster the development of junior scientists. An Administrative Coordinating Core will continue to synergize all TMARC activities by way of an Executive Unit, which oversees Units on Data Management and Information Systems, Statistics, and Participant accrual and tracking. Thus, in the renewal period, TMARC endeavors to expand its role as a local and national resource for translational multidisciplinary research and training in the neuroscience of addictions and neuroAIDS.

Public Health Relevance

Effective antiretroviral therapy (ART) has decreased mortality and extended the life span of those living with HIV. As people with HIV age, understanding the combined effects of HIV, METH, and aging becomes a significant public health concern. Building on prior accomplishments, TMARC will continue to provide leadership and training in innovative translational research on the effects of HIV and METH. OVERALL CENTER CHARACTERISTICS

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
2P50DA026306-06
Application #
8601231
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Lin, Yu
Project Start
2008-12-01
Project End
2019-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Oppenheim, Hannah; Paolillo, Emily W; Moore, Raeanne C et al. (2018) Neurocognitive functioning predicts frailty index in HIV. Neurology 91:e162-e170
Walker, Keenan A; Brown, Gregory G (2018) HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis. J Clin Exp Neuropsychol 40:357-376
Stecher, Melanie; Hoenigl, Martin; Eis-Hübinger, Anna Maria et al. (2018) Hotspots of Transmission Driving the Local Hiv Epidemic in the Cologne-Bonn Region, Germany. Clin Infect Dis :
Paolillo, Emily W; Obermeit, Lisa C; Tang, Bin et al. (2018) Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use in older adults with and without HIV infection. Addict Behav 83:102-108
Thaney, Victoria E; Kaul, Marcus (2018) Type I Interferons in NeuroHIV. Viral Immunol :
Soontornniyomkij, Virawudh; Umlauf, Anya; Soontornniyomkij, Benchawanna et al. (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32:2005-2015
Thaney, Victoria E; Sanchez, Ana B; Fields, Jerel A et al. (2018) Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol 24:156-167
Kesby, James P; Chang, Ariel; Markou, Athina et al. (2018) Modeling human methamphetamine use patterns in mice: chronic and binge methamphetamine exposure, reward function and neurochemistry. Addict Biol 23:206-218
Hoenigl, Martin; Jain, Sonia; Moore, David et al. (2018) Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1. Emerg Infect Dis 24:
Moore, David J; Pasipanodya, Elizabeth C; Umlauf, Anya et al. (2018) Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial. Drug Alcohol Depend 189:154-160

Showing the most recent 10 out of 148 publications